How Has the Home Infusion Therapy Market Evolved Historically and What is its Current Size?
The home infusion therapy market has seen considerable growth due to a variety of factors.
• The market size for home infusion therapy has experienced a significant expansion in the previous years. It's expected to soar from $32.15 billion in 2024 to $35.69 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.0%.
Aspects such as the growing aging population, an incline in patient preference, a rise in chronic illnesses, and the increasing avoidance of hospitals have all contributed to the growth during the historic era.
What is the Forecasted Market Size and CAGR for the Home Infusion TherapyMarket?
The home infusion therapy market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for home infusion therapy is predicted to experience quick expansion in the upcoming years, reaching $52.78 billion by 2029 with a compound annual growth rate (CAGR) of 10.3%.
This surge during the projected period can be traced back to factors such as the integration of telehealth, the advancement of personalized medicine, increased pandemic readiness, patient empowerment, and the rise of value-based care models. The forecast period is also likely to notice significant trends like innovative infusion devices, biologic and specialty drugs, home infusion for children, infusion pump safety, and patient instruction and training.
What Are The Primary Growth Drivers In The Home Infusion Therapy Market?
The growth of the home infusion therapy market is anticipated to be driven by an escalating population and subsequent surge in food demand. Food, which comprises protein, carbohydrates, fat and additional nutrients, is employed in an organism's body to support growth, vital processes and render energy. It is a crucial element for patients engaged in home infusion therapy, and this amplified population has resulted in a growing number of elderly individuals needing home infusion therapy. For instance, according to information from the United Nations, in the coming 30 years the world’s population is predicted to rise by 2 billion, from the present 7.7 billion to 9.7 billion by 2050. Furthermore, data from Intechnopen, a publication based in London predicts a global increase in food demand by 70% by 2050. Hence, the growing population and its subsequent effect on food demand is expected to fuel the expansion of the home infusion therapy market.
What Is The Segmentation Of The Global Home Infusion Therapy Market?
The home infusion therapy market covered in this report is segmented –
1) By Product: Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors
2) By Administration: Intramuscular, Subcutaneously, Epidural
3) By Application: Total Parenteral Nutrition?, Anti-infective Therapy, Enteral Nutrition, Hydration Therapy, Chemotherapy, IVIg or Specialty Pharmaceuticals, Other Applications
4) By End User: Patients, Nurse, Hospitals, Other End Users
Subsegments:
1) By Infusion Pumps: Electronic Infusion Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps
2) By Intravenous Sets: Standard IV Sets, Blood Administration Sets, IV Extension Sets
3) By IV Cannulas: Peripheral IV Cannulas, Central Venous Catheters (CVCs), Midline Catheters
4) By Needleless Connectors: Luer-Lock Needleless Connectors, Valved Needleless Connectors, Non-Valved Needleless Connectors
Pre-Book The Home Infusion Therapy Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Home Infusion Therapy Market Landscape?
The predominant trend prevailing in the home infusion therapy market is the establishment of strategic alliances and partnerships. Major players in the sector are leveraging partnerships to consolidate their market standing. For example, in April 2022, CarepathRx, a prominent US-based pharmacy and medication management solutions provider, entered into a partnership with Mount Sinai Health System, a hospital network also based in the US. This alliance facilitates the expansion of patient accessibility to home infusion therapies throughout the Mount Sinai Health System, which includes its eight hospitals and ambulatory services.
Who Are the Key Players in the Home Infusion Therapy Market?
Major companies operating in the home infusion therapy market include:
• B. Braun Melsungen AG
• Baxter International Inc.
• Fresenius Kabi AG
• Option Care Health Inc.
• CareCentrix Inc.
• Caesarea Medical Electronics Ltd.
• JMS Co. Ltd.
• Terumo Corporation
• Smiths Medical ASD Inc.
• Optum Inc.
• CVS Health Corporation
• KabaFusion Holdings LLC.
• PromptCare Companies
• Nipro Corporation
• ICU Medical Inc.
• Becton Dickinson and Company
• Ascension at Home with Compassus
• Barnes Healthcare Services Inc.
• BayCare HomeCare Inc.
• ARJ Infusion Services Inc.
• Beacon Infusion Healthcare Services LLC.
• CarepathRx LLC.
• Coram CVS Specialty Infusion Services
• CSI Pharmacy LLC.
• Fairview Home Infusion
• Healix Infusion Therapy Inc.
• InfuCare Rx Inc.
• Integrated Home Care Services Inc.
• IVX Health Inc.
• Kroger Specialty Infusion
• Metro Infusion Center
• National Pharmacy Services LLC.
• Nations Home Infusion LLC.
• Oso Home Care LLC.
• Palmetto Infusion Services LLC.
• Penn Home Infusion Therapy
• The PharmaCare Network Inc.
• PICC Lines Plus LLC.
• Premier Infusion Care LLC.
• Basic Home Infusion Inc.
What are the Regional Insights into the Home Infusion Therapy Market?
North America was the largest region in the home infusion therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the home infusion therapy market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
